UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 143

Sortiert nach

Challenges and Gaps in Understanding Substance Use Problems in Transitional Age Youth

Child and adolescent psychiatric clinics of North America, 2017-04, Vol.26 (2), p.253-269

Bukstein, Oscar G., MD, MPH

2017

Volltextzugriff (PDF)

Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders

Journal of the American Academy of Child and Adolescent Psychiatry, 2020-10, Vol.59 (10), p.1107-1124

2020

Volltextzugriff (PDF)

Severely Aggressive Children Receiving Stimulant Medication Versus Stimulant and Risperidone: 12-Month Follow-Up of the TOSCA Trial

Journal of the American Academy of Child and Adolescent Psychiatry, 2016-06, Vol.55 (6), p.469-478

2016

Volltextzugriff (PDF)

Double-blind fluoxetine trial in comorbid MDD–CUD youth and young adults

Drug and alcohol dependence, 2010-11, Vol.112 (1), p.39-45

2010

Volltextzugriff (PDF)

Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Major and Persistent Depressive Disorders

Journal of the American Academy of Child and Adolescent Psychiatry, 2023-05, Vol.62 (5), p.479-502

2023

Volltextzugriff (PDF)

Clonidine for Attention-Deficit/Hyperactivity Disorder: I. Efficacy and Tolerability Outcomes

Journal of the American Academy of Child and Adolescent Psychiatry, 2008-02, Vol.47 (2), p.180-188

2008

Volltextzugriff (PDF)

Management of the Adolescent with Substance Use Disorders and Comorbid Psychopathology

Child and adolescent psychiatric clinics of North America, 2010-07, Vol.19 (3), p.609-623

2010

Volltextzugriff (PDF)

Clonidine for Attention-Deficit/Hyperactivity Disorder: II. ECG Changes and Adverse Events Analysis

Journal of the American Academy of Child and Adolescent Psychiatry, 2008-02, Vol.47 (2), p.189-198

2008

Volltextzugriff (PDF)

Sexual orientation and adolescent substance use: a meta-analysis and methodological review

Addiction (Abingdon, England), 2008-04, Vol.103 (4), p.546-556

2008

Volltextzugriff (PDF)

Practice Parameter for the Assessment and Treatment of Psychiatric Disorders in Children and Adolescents With Intellectual Disability (Intellectual Developmental Disorder)

Journal of the American Academy of Child and Adolescent Psychiatry, 2020-04, Vol.59 (4), p.468-496

2020

Volltextzugriff (PDF)

The treatment of severe child aggression (TOSCA) study: Design challenges

Child and adolescent psychiatry and mental health, 2011-11, Vol.5 (1), p.36-36, Article 36

2011

Volltextzugriff (PDF)

Forward to the Future: Clinical Updates and Clinical Practice Guidelines

Journal of the American Academy of Child and Adolescent Psychiatry, 2017-10, Vol.56 (10), p.811-812

2017

Volltextzugriff (PDF)

Comorbid substance use disorders among youth with bipolar disorder: opportunities for early identification and prevention

The journal of clinical psychiatry, 2010-03, Vol.71 (3), p.348

2010

Volltextzugriff (PDF)

Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: A multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials

Clinical therapeutics, 2009-08, Vol.31 (8), p.1844-1855

2009

Volltextzugriff (PDF)

Measurement-Based Care in the Treatment of Adolescents with Substance Use Disorders

Child and adolescent psychiatric clinics of North America, 2020-10, Vol.29 (4), p.675-690

2020

Volltextzugriff (PDF)

What Does Risperidone Add to Parent Training and Stimulant for Severe Aggression in Child Attention-Deficit/Hyperactivity Disorder?

Journal of the American Academy of Child and Adolescent Psychiatry, 2014, Vol.53 (1), p.47-60.e1

2014

Volltextzugriff (PDF)

Taking Note of Over-the-Counter Remedies for Adolescents With Cannabis Dependence

American Journal of Psychiatry, 2012-08, Vol.169 (8), p.771-773

Bukstein, Oscar G

2012

Volltextzugriff (PDF)

Effects of Extended-Release Methylphenidate Treatment on Cognitive Task Performance in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder

Journal of child and adolescent psychopharmacology, 2020-09, Vol.30 (7), p.414

2020

Volltextzugriff (PDF)

Risperidone Added to Parent Training and Stimulant Medication: Effects on Attention-Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder, Conduct Disorder, and Peer Aggression

Journal of the American Academy of Child and Adolescent Psychiatry, 2014-09, Vol.53 (9), p.948-959.e1

2014

Volltextzugriff (PDF)

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Substance Use Disorders

Journal of the American Academy of Child and Adolescent Psychiatry, 2005-06, Vol.44 (6), p.609-621

Bukstein, Oscar G.

2005

Volltextzugriff (PDF)

Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms

Journal of child and adolescent psychopharmacology, 2013-06, Vol.23 (5), p.337

2013

Volltextzugriff (PDF)

Clinical Implications From the Treatment of Severe Childhood Aggression (TOSCA) Study: A Re-Analysis and Integration of Findings

Journal of the American Academy of Child and Adolescent Psychiatry, 2017-12, Vol.56 (12), p.1026-1033

2017

Volltextzugriff (PDF)

Attention deficit hyperactivity disorder and substance use disorders

Current topics in behavioral neurosciences, 2012, Vol.9, p.145

Bukstein, Oscar G

2012

Volltextzugriff (PDF)

Brief screens for detecting alcohol use disorder among 18-20 year old young adults in emergency departments: Comparing AUDIT-C, CRAFFT, RAPS4-QF, FAST, RUFT-Cut, and DSM-IV 2-Item Scale

Addictive behaviors, 2009-08, Vol.34 (8), p.668-674

2009

Volltextzugriff (PDF)

Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder?

Child and adolescent psychiatry and mental health, 2009-12, Vol.3 (1), p.39-39, Article 39

2009

Volltextzugriff (PDF)

1 – 25 von 143

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(128)
Mit Volltextzugriff
(116)

Publikationsform

Sprache

Englisch
(143)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(90)
Life Sciences & Biomedicine
(89)
Science & Technology
(89)
Psychiatry
(74)
Male
(61)
Psychology
(60)
Social Sciences
(60)
Female
(59)
Adolescent
(55)
Child
(54)
Pediatrics
(50)
Psychology, Developmental
(42)
Adolescents
(38)
Biological And Medical Sciences
(37)
Medical Sciences
(37)
Psychology. Psychoanalysis. Psychiatry
(37)
Psychopathology. Psychiatry
(33)
Teenagers
(33)
Comorbidity
(32)
Attention Deficit Hyperactivity Disorder
(31)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Challenges and Gaps in Understanding Substance Use Problems in Transitional Age Youth

Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders

Severely Aggressive Children Receiving Stimulant Medication Versus Stimulant and Risperidone: 12-Month Follow-Up of the TOSCA Trial

Double-blind fluoxetine trial in comorbid MDD–CUD youth and young adults

Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Major and Persistent Depressive Disorders

Clonidine for Attention-Deficit/Hyperactivity Disorder: I. Efficacy and Tolerability Outcomes

Management of the Adolescent with Substance Use Disorders and Comorbid Psychopathology

Clonidine for Attention-Deficit/Hyperactivity Disorder: II. ECG Changes and Adverse Events Analysis

Sexual orientation and adolescent substance use: a meta-analysis and methodological review

Practice Parameter for the Assessment and Treatment of Psychiatric Disorders in Children and Adolescents With Intellectual Disability (Intellectual Developmental Disorder)

The treatment of severe child aggression (TOSCA) study: Design challenges

Forward to the Future: Clinical Updates and Clinical Practice Guidelines

Comorbid substance use disorders among youth with bipolar disorder: opportunities for early identification and prevention

Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: A multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials

Measurement-Based Care in the Treatment of Adolescents with Substance Use Disorders

What Does Risperidone Add to Parent Training and Stimulant for Severe Aggression in Child Attention-Deficit/Hyperactivity Disorder?

Taking Note of Over-the-Counter Remedies for Adolescents With Cannabis Dependence

Effects of Extended-Release Methylphenidate Treatment on Cognitive Task Performance in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder

Risperidone Added to Parent Training and Stimulant Medication: Effects on Attention-Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder, Conduct Disorder, and Peer Aggression

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Substance Use Disorders

Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms

Clinical Implications From the Treatment of Severe Childhood Aggression (TOSCA) Study: A Re-Analysis and Integration of Findings

Attention deficit hyperactivity disorder and substance use disorders

Brief screens for detecting alcohol use disorder among 18-20 year old young adults in emergency departments: Comparing AUDIT-C, CRAFFT, RAPS4-QF, FAST, RUFT-Cut, and DSM-IV 2-Item Scale

Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder?

Suchergebnisse filtern